The observation that heparanase can confer chemotherapeutic resistance in cancer cells (reviewed in [148]) led to the discovery that the chemotherapies bortezomib, carfilzomib, and doxorubicin can induce the upregulation of heparanase in vitro [76]. This evidence concerns the gene HPSE and cancer.